Halina Offner
Corporate Officer/Principal en Artielle ImmunoTherapeutics, Inc. .
Cargos activos de Halina Offner
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/2004 | - |
| Fundador | 01/01/2004 | 18/11/2014 | |
| Oregon Health & Science University | Corporate Officer/Principal | - | - |
Historial de carrera de Halina Offner
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Halina Offner
- Experiencia
